Nataliia Novosolova

Dr. Nataliia Novosolova

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Redox Biology
Verified
Journal Article
Open access
NNNataliia Novosolova
Nataliia Novosolova
NBN. Braidotti
N. Braidotti
TPT. Patinen
T. Patinen
TLT. Laitinen
T. Laitinen
CCC. Ciubotaru
C. Ciubotaru
TMT. Malm
T. Malm
Emerging evidence suggests that mechanosensitive Piezo1 channels play a role in the pathomechanism of various disorders. However, the mechanisms by which accumulating pathologies regulate Piezo1 activation remain unclear. Oxidative stress, a common feature of neurodegenerative diseases, is associated with generation of reactive oxygen species (ROS). While the dependence of Piezo1 channels on temperature, pH, and voltage has been well studied, the redox regulation of these highly mechanosensitive channels remains unknown. We investigated whether oxidative stress modulates the calcium permeability of Piezo1 channels using red blood cells (RBCs) and HEK293T cells transduced with Piezo1 as model systems. Additionally, using the selective H2O2 sensor HyPer7, we examined whether Piezo1 activation induces the generation of endogenous ROS. Using flow cytometry, Ca2+-imaging, patch clamp and microaspiration techniques we demonstrate that cell-permeable oxidants hydrogen peroxide (H2O2) and Chloramine-T, which specifically oxidize cysteines and methionines, inhibited Yoda1-induced activation of Piezo1 in both cell types. In contrast to Chloramine-T, the membrane-impermeable, cysteine-specific oxidant DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) also inhibited Piezo1, although its inhibitory effect was less pronounced. Mechanical sensitivity of Piezo1 was reduced by H2O2 also in RBCs. Scavenging antioxidants N-acetylcysteine and dithiothreitol decreased or eliminated the inhibitory action of H2O2 and Chloramine-T. However, overexpression of the antioxidant transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) did not prevent the inhibitory effects of Chloramine-T, suggesting a membrane-delimited site of redox modulation. Notably, Piezo1 activation slightly increased endogenous H2O2 production. Our data suggest that the reduced activity of Piezo1 in the oxidative environment is determined by oxidation of both cysteines and methionines, which are enriched in intracellular domains, with methionines playing a predominant role. Given the role of Piezo1 channels in pathophysiology of numerous disorders, we propose that, under conditions associated with oxidative stress, redox modulation of these mechanosensors could be a significant factor contributing to disease pathology.

7 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
Antonios G. DougalisAntonios G. Dougalis
Antonios G. Dougalis
PAPolina A. A. Abushik
Polina A. A. Abushik
APAnssi Pelkonen
Anssi Pelkonen
LGLuca Giudice
Luca Giudice
MGMireia Gómez-Budia
Mireia Gómez-Budia
TMTarja Malm
Tarja Malm
Studies of neuronal functions during the pathological progression of Alzheimer’s disease (AD) in humans are limited due to the lack of live human brain tissue from patients with AD. To address this gap, we have established an exceptional approach to study the electrophysiological properties and cell morphologies of human neurons in acute slices obtained from cortical biopsies of patients with idiopathic normal pressure hydrocephalus (iNPH). Histological examination of Broadman area 8-9 cortical biopsies from these patients have revealed that approximately 40% of the patients show signs of early AD-related pathology in the form of low to moderate, often fleecy beta-amyloid (Aβ) deposits and additional, occasional tau in 10% of the cases. Thus, the iNPH brain biopsies, obtained during the shunt surgery to treat the patients, offer a unique window to investigate how existing AD-related pathology alters the operational properties of human cortical neurons. Here we carried out integrative analysis of human neuronal electrophysiology at single neuron and network level followed by subsequent cellular morphological reconstructions to register the primary pathological changes in neuronal functions in correlation with existing AD-related pathology. The presence of Aβ plaques induced a decrease in basal excitatory synaptic activity in pyramidal neurons residing on supragranular layers of the cortex. These neurons received less of L1-induced inhibition and appeared hyperexcitable in response to application to NMDA in multielectrode array (MEA) recordings. Interestingly, the global spine density of supraganular pyramidal neurons was increased in biopsies with AD-related pathology. The increase in spine density was coincidental with a partial recovery of excitatory transmission (frequency but not amplitude), of L1-induced inhibition in supragranular layers pyramidal neurons and of NMDA induced supragranular firing (but not of bursting hyperexcitability) indicating a potential differential effect of tau in the presence of Aβ on the progression of neuronal functions. Despite the partial renormalization of deficits seen in cases with Aβ pathology only, pyramidal neurons in cases with both Aβ and tau exhibited more consistent deficits in the intrinsic neuronal properties with increase in sodium and potassium currents and a strong propensity to bursting under NMDA stimulation. We conclude that complex mechanisms operate in response to accumulation of Aβ and tau including re-structuring of the apparatus of synaptic transmission and consolidation of a hyperexcitable supragranular cortical network phenotype. The observed changes in spine density and synaptic activity are reminiscent of parallels seen in homeostatic plasticity and synaptic scaling and may depend on strong interactions with the local microenvironment (astrocytes and microglia). This is the first study to report the impact of AD-related pathology on single-neuron operational properties and morphology in humans.

Verified
Journal Article
Open access
PDF file
GTGauhar Tassibekova
Gauhar Tassibekova
MZManzura Zholdassova
Manzura Zholdassova
NNNataliia Novosolova
Nataliia Novosolova
TMTarja Malm
Tarja Malm
Rashid GiniatullinRashid Giniatullin
Rashid Giniatullin
AKAlmira M Kustubayeva
Almira M Kustubayeva
The intestinal microbiota, a diverse community of microorganisms residing in the human gut, recently attracted considerable attention as a contributing factor to various neurological disorders, including Alzheimer’s Disease (AD). Within the established framework of the gut–brain axis (GBA) concept, it is commonly suggested that dysbiosis, through microbial metabolites entering the brain, affect the cognitive functions in patients with AD. However, evidence for such a role of dysbiosis remains largely associative, and the complexity of the communication channels between the gut and the brain is not fully understood. Moreover, the new players of the GBA are emerging and the AD concept is constantly evolving. The objective of this narrative review is to synthesize the current evidence on the humoral, endocrine, immune, and neural communication mechanisms linking the gut and brain in AD and highlight newly discovered GBA messengers such as microRNAs, extracellular vesicles, T-cells, and the intestinal hormones, including emerging neuroprotective role for glucagon-like peptide-1 (GLP-1). Based on this knowledge, we aimed to develop a conceptual understanding of the GBA function in health and AD. We specify that, in AD, the GBA goes beyond a disrupted microbiome, but operates in conjunction with impaired intestinal secretion, motility, barrier permeability, and neuroinflammatory signaling. These factors are associated with the dysfunction of the hypothalamic–pituitary axis, altered somatic and autonomic neuronal gut regulation, and abnormal, due to memory problems, behavioral aspects of food intake. Identifying the individual profile of key molecular and cellular players contributing to an unbalanced GBA should optimize existing approaches or propose new approaches for the complex therapy of AD.

26 June 2017 in Biochemistry
Verified
Journal Article
Closed access
YIYevheniia Ishchenko
Yevheniia Ishchenko
NNNataliia Novosolova
Nataliia Novosolova
KKKamil Khafizov
Kamil Khafizov
GBGeneviève Bart
Geneviève Bart
ATArina Timonina
Arina Timonina
Rashid GiniatullinRashid Giniatullin
Rashid Giniatullin

20 April 2025 in bioRxiv
Verified
Preprint
Open access
JKJenni Kyyriäinen
Jenni Kyyriäinen
APAdriana Della Pietra
Adriana Della Pietra
MTMastaneh Torkamani-Azar
Mastaneh Torkamani-Azar
MGMireia Gómez-Budia
Mireia Gómez-Budia
PAPolina Abushik
Polina Abushik
ASAlejandra Sierra
Alejandra Sierra
Objective: We have established a comprehensive sample handling protocol designed for the multiscale assessment of epileptogenic tissue. This protocol aims to identify novel therapeutic targets and enhance the diagnosis and stratification of patients with drug-resistant epilepsy, thereby optimizing their treatment with anti-seizure medications and surgical interventions. Methods: Patients with drug-resistant focal epilepsy, recommended for surgical treatment, are recruited after detailed multidisciplinary preoperative evaluation at the Epilepsy Center at Kuopio University Hospital in Finland. A day before the resective surgery, patients undergo magnetic resonance imaging (MRI) including advanced methodologies. During the surgery, each piece of resected tissue is placed under oxygenation on ice-cold artificial cerebral spinal fluid-solution. The pieces are then immediately transported to the laboratory, assessed by a neuropathologist, and sliced for both clinical diagnosis and research. Two adjacent slices are provided for research and are sent to the University of Eastern Finland. Results: The developed sample handling protocol provides the opportunity for detailed characterization of the tissue from the same patient using emerging imaging, electrophysiology, and molecular biology technologies. We have optimized the conditions for preserving the resected tissue alive for electrophysiological measurements and simultaneously making possible ex vivo studies including multi-omics acquisition, electron microscopy, histology, and MRI. Our protocol enables the mapping of functional readouts to structural and molecular alterations in human tissue. Our goal is to integrate multimodal data and co-register the resected tissues within the whole brain’s in vivo MRI space. This approach aims to enhance the characterization and localization of epileptogenic zones and refine surgical treatment targets by identifying abnormalities in global connectivity and structural patterns. Significance: We have successfully developed a systematic protocol for the collection and analysis of multimodal data. This protocol aims to elucidate the structural, functional, and molecular characteristics that render tissue epileptogenic, thereby enhancing the diagnosis and subsequent care of patients with epilepsy. Key points: Introducing a systematic sample handling protocol to assess tissue epileptogenicity at structural, functional and molecular levels. A multimodal approach integrating advanced technology with detailed characterization of epileptogenic tissue properties to obtain patient-specific data. Correlation of data from preoperative MRI and resected tissue to predict tissue pathology from clinical MRI.